Healthcare

Danish Drug Maker Becomes Most Valuable Company in UK

The Danish Pharmaceutical group known as Novo Nordisk has become Europe’s most valuable company after the group introduced its extremely successful weight-loss drug Wegovy.

Continue reading →

Eli Lilly's Revolutionary Obesity Treatment Drug

Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday.

Continue reading →

Astellas Acquires Iveric in $6 Billion Deal

The Japanese pharmaceutical company known as Astellas Pharma has agreed to buy the U.S. biotech group Iveric Bio for just under $6 billion. The recent announcement of the deal marks Astellas' biggest acquisition for the company since it started looking to expand overseas back in 2007.

Continue reading →

Breakthrough in Cancer Vaccines

Moderna and Merck & Co. have made a breakthrough with their cancer vaccine in which a recent trial has provided significant evidence that the use of a shot to jump-start the immune system can be beneficial in warding off further development of cancer cells.

Continue reading →

Pfizer-Seagen Deal Increases to $40 Billion

As previously reported by Brookfield Brief, Pfizer was looking to acquire the biotech company Seagen Inc. to further the company's capabilities in cancer treatment.

Continue reading →

COVID Vaccine Manufacturer Warns It May Not Survive

Five weeks into his job as the new CEO as Novavax, John Jacobs raised the possibility on Tuesday afternoon that the company may not survive 2023.

Continue reading →

Pfizer to Acquire Seagen for Over $30 Billion

Pfizer is looking to further expand its global prominence as the company has now set its eyes on acquiring Seagen Inc. which would further Pfizer’s capabilities within cancer therapies.

Continue reading →

Biden Administration Purchasing 1.5 Million Novavax Vaccines

The United States government has agreed to purchase another 1.5 million Covid-19 vaccines from the company Novavax Inc.

Continue reading →

CVS Acquiring Primary Care Provider Oak Street for $10.5 Billion

CVS is close to an agreement to acquire Oak Street Health for about $10.5 billion including debt, a deal that would rapidly expand the big healthcare company’s footprint of primary-care doctors with a large network of senior-focused clinics.

Continue reading →

Arrival in Hot Water

It has been a rough start to the year for electric van manufacturer Arrival as the UK-based company announced it will cut jobs to reduce costs.

Continue reading →

GE Healthcare Begins Trading

General Electric will start 2023 by splitting off its healthcare unit, completing a key step in the slow-motion breakup of the industrial giant. For the rest of the year it will face questions about the next big step: shedding its power businesses.

Continue reading →

VillageMD to Buy Summit Health for $9 Billion

Walgreens-backed VillageMD has agreed to buy urgent care provider Summit Health in a deal valued at nearly $9 billion.

Continue reading →

Pfizer Faces Losses

Pfizer CEO Albert Bourla laid out his plan Tuesday to keep the pharmaceutical giant growing through 2030, as the Covid-19 pandemic fades and the company faces generic competition for some of its blockbuster drugs.

Continue reading →

Amazon's Jump Into Healthcare

Amazon is looking to expand further into the healthcare industry as the company has made a bid to secure Signify Health Inc., an in-home health service provider that could be valued at as much as $8 billion.

Continue reading →

Pfizer Developing Lyme Disease Vaccine

After Pfizer’s dominant global success with the Covid-19 vaccine the U.S.-based company has continued to expand outward by purchasing an 8.1% stake, worth roughly $95 million in the French vaccine company Valneva as the two companies work to develop a Lyme disease vaccine.

Continue reading →

Advancements in COVID-19 Treatment

Vaccinations appear to be all the rage when it comes to mitigating the severity of the Covic-19 pandemic, however, a biotechnology company known as AstraZeneca has been furthering advancements in Covid-19 treatment that the company says can reduce the development of severe Covid symptoms and even deaths by 50%

Continue reading →

FDA Approves First New Alzheimer's Drug In Two Decades

The first drug showing promise to slow Alzheimer’s disease was approved by U.S. health regulators after years of research and billions of dollars in investment.The United States Food and Drug Administration said it approved the Biogen created drug, which has the molecular name aducanumab and will be sold as Aduhelm, based on evidence it reduces a sticky substance in the brain called amyloid that is associated with Alzheimer’s

Continue reading →

Potential Breakthrough in the Fight Against Cancer

A recent breakthrough in cancer treatment occurred Friday when Amgen Inc.’s new drug known as Lumakras was approved by the Food and Drug Administration. Amgen Inc.’s new drug Lumakras is designed to treat a mutation of lung cancer known as KRAS. This mutation is the most common among lung cancers and previously was believed to be untreatable by the use of drugs

Continue reading →

Vaccination Passports? Here's What We Know

As COVID-19 vaccinations are spreading around the world, limitations on travel have continued to weaken. Countries such as Italy, Iceland, Greece and Spain have already begun to allow for international travel with proof of COVID-19 vaccinations, however, governments and airlines are now discussing what methods should be used to prove that a traveler has immunity to the virus

Continue reading →

Walmart's Segway Into Healthcare

Walmart continued its expansion into the healthcare realm when on Thursday the company purchased the telehealth provider MeMD and plans to offer virtual healthcare services to customers and employees. Walmart’s plan to expand into the virtual healthcare market is in response to Amazon beginning to offer health care services to employees through their platform known as Amazon Care

Continue reading →

Low-Quality Foreign Made Masks in US Supply

05.05.20 - U.S. regulators and state officials are finding that a significant number of imported N95-style masks are falling short of certification standards, complicating the response to the coronavirus crisis and potentially putting some front-line workers at greater risk

Continue reading →

First US Human Trial of Potential COVID-19 Vaccine Set to Start

03.16.20 - According to the Associated Press, the first US human clinical trial of a potential vaccine for the new coronavirus will begin Monday. The trial, which will test the effects of an experimental vaccine shot developed by the National Institutes of Health and drug maker Moderna, won’t make use of either an active or inactive sample of the virus, as is common for vaccines, but will instead use a gene-based method that uses messenger RNA to trigger an immune response in the target individual

Continue reading →

CoronaVirus Spurs Movement to End China’s Chokehold on Pharma

03.16.20 - If this crisis has exposed anything, it is how imperative it is that we keep pharmaceutical supply chains within our own borders. We have laws that prevent the manufacturing of our defensive equipment and weapons outside of our borders for the sake of national security. These laws need to extend to medical devices and pharmaceuticals, as this extends to national security our public health is national security

Continue reading →

California Lab Cracks Corona Virus In 3 Hours?

02.17.20 - A Pennsylvania based biotech company Inovio Pharmaceuticals says it created a coronavirus vaccine three hours after getting access to the virus' genetic sequence on Jan. 9 in it’s San Deigo laboratory, and now scientists are racing to get the vaccine on the market in record time

Continue reading →